The fourth Asia Partnership Conference of Pharmaceutical Associations (APAC) was held on 9-10 April at the Palace Hotel Tokyo. Out of 13 IFPMA members in Asia, this conference was attended by 11 pharmaceutical associations from China (RDPAC), Hong Kong (HKAPI), Indonesia (IPMG), Malaysia (PhAMA), Philippines (PHAP), Singapore (SAPI), Korea (KPMA and KRPIA), Taiwan (IRPMA), Thailand (PReMA) and Japan (JPMA). In addition, participants from IFPMA, Interpharma, government officials from Indonesia, Korea, Malaysia, Myanmar, Taiwan, Thailand, and Japan (Minister of MHLW, MHLW, PMDA and AMED) were also there to participate in the conference and reception, bringing the total number of participants to approximate 300 altogether.
Regulations and Approvals Expert Working Group (RA EWG)
Drug Discovery Alliance Expert Working Group (DA EWG)
DAEWG strives to continue developing a platform for open innovation through three core activities: the provision of opportunities for information sharing in research, the promotion of networking in development, and drug discovery capacity building for researchers. By means of these core activities, we will provide solutions to our challenges in collaboration with our stakeholders.